Financial Support Improves Treatment Outcomes for Multidrug-Resistant Tuberculosis
Author Information
Author(s): Chen Yong, Shen Xin, Zhang Yi, Wu Zheyuan, Xu Biao, Chen Jing, Sha Wei, Liu Xiaoxia, Ning Chenxi
Primary Institution: Shanghai Municipal Center for Disease Control and Prevention
Hypothesis
Does financial support positively influence treatment outcomes for MDR-TB patients?
Conclusion
Financial support policies for MDR-TB patients demonstrate a positive influence on treatment outcomes.
Supporting Evidence
- 70.6% of patients achieved treatment success.
- The median amount compensated under the subsidy policy was 2359 USD.
- Patients benefiting from the subsidy policy had a higher rate of treatment success.
- Financial support reduced out-of-pocket payments for patients.
- Patients with higher reimbursement had better treatment outcomes.
Takeaway
Helping people pay for their medicine can make them get better from a serious illness called MDR-TB.
Methodology
The study used multivariate logistic regression to assess the association between financial support and treatment outcomes of MDR-TB patients.
Potential Biases
Potential biases were mitigated by the well-established MDR-TB control network in Shanghai.
Limitations
The study lacked individual and household financial situations and did not systematically collect data on the quality of patient management.
Participant Demographics
Approximately 70% of the patients were male, with a mean age of 43.7 years.
Statistical Information
P-Value
0.008
Confidence Interval
95% CI, 2.03–4.28
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website